cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2023-3666YRHRNIcardiovascular-3666Research ArticleМЕТОДИЧЕСКИЕ РЕКОМЕНДАЦИИMETHODICAL GUIDELINESОценка клинического и амбулаторного артериального давления в практической работе врача первичного звена здравоохранения. Методические рекомендацииEvaluation of office and ambulatory blood pressure in the practice of a primary care physician. Guidelineshttps://orcid.org/0000-0001-5195-8997ГорбуновВ. М.GorbunovV. M.

Владимир Михайлович Горбунов — доктор медицинских наук, руководитель лаборатории применения амбулаторных диагностических методов в профилактике хронических неинфекционных заболеваний отдела первичной профилактики хронических неинфекционных заболеваний в системе здравоохранения ФГБУ "НМИЦ ТПМ" Минздрава России

vmgorbunov@gmail.comhttps://orcid.org/0000-0002-6208-3038СмирноваМ. И.SmirnovaM. I.

Руководитель лаборатории профилактики хронических болезней органов дыхания отдела первичной профилактики хронических неинфекционных заболеваний в системе здравоохранения ФГБУ «НМИЦ ТПМ» Минздрава России, к.м.н. 

MSmirnova@gnicpm.ruhttps://orcid.org/0000-0001-8498-7030КурехянА. С.KurekhyanA. S.

Армине Сарибековна Курехян — кандидат медицинских наук, научный сотрудник лаборатории профилактики хронических болезней органов дыхания отдела первичной профилактики хронических неинфекционных заболеваний в системе здравоохранения ФГБУ "НМИЦ ТПМ" Минздрава России

arminesar@mail.ruhttps://orcid.org/0000-0002-4453-8430ДрапкинаО. М.DrapkinaO. M.

Оксана Михайловна Драпкина — доктор медицинских наук, профессор, академик РАН, директор

ODrapkina@gnicpm.ruМинистерство здравоохранения Российской Федерации; ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России Российское общество профилактики неинфекционных заболеваний (РОПНИЗ)Ministry of Health of the Russian Federation; National Medical Research Center for Therapy and Preventive Medicine Russian Society for the Prevention of Noncommunicable Diseases20230509202322736663666Copyright © Горбунов В.М., Смирнова М.И., Курехян А.С., Драпкина О.М., 20232023Горбунов В.М., Смирнова М.И., Курехян А.С., Драпкина О.М.Gorbunov V.M., Smirnova M.I., Kurekhyan A.S., Drapkina O.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/3666

Методические рекомендации содержат сведения о современных подходах к оценке уровня артериального давления, основных правилах его измерения, об интерпретации данных, составлении заключений, в т.ч. при совместной оценке результатов клинических и амбулаторных измерений. Отражены сведения о постановке диагноза "артериальная гипертония", оценке эффективности антигипертензивной терапии с помощью клинических и амбулаторных измерений артериального давления, как при отдельном, так и совместном их применении. Кратко освещены аспекты, связанные с измерением артериального давления в ортостазе, диагностикой гипотонии. Методические рекомендации предназначены для врачей первичного звена здравоохранения (терапевтов, врачей общей практики, кардиологов, неврологов и других специалистов), учащихся медицинских ВУЗов и учреждений последипломного образования.

The guidelines contain data on modern approaches to blood pressure assessment, the basic rules for its measurement, data interpretation, making conclusion, including with combined evaluation of clinical and ambulatory measurement data. Information on the diagnosis of hypertension, evaluation of the effectiveness of antihypertensive therapy using clinical and ambulatory blood pressure measurement, both with their separate and combined use, is reflected. Aspects related to the measurement of blood pressure when standing and the diagnosis of hypotension are briefly covered. The guidelines are intended for primary care physicians (internists, general practitioners, cardiologists, neurologists and other specialists), students of medical universities and postgraduate education institutions.

артериальная гипертонияклиническое артериальное давлениеамбулаторное артериальное давлениеортостатическая гипотензиясуточное мониторирование артериального давлениягипертония белого халатаскрытая артериальная гипертонияhypertensionoffice blood pressureambulatory blood pressureorthostatic hypotensionambulatory blood pressure monitoringwhite coat hypertensionmasked hypertensionnoneReferencesStergiou GS, Palatini P, Parati G, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293302. doi:10.1097/HJH.0000000000002843.Stergiou GS, Palatini P, Parati G, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293302. doi:10.1097/HJH.0000000000002843.Stergiou GS, Alpert B, Mieke S, et al. A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. Hypertension. 2018;71(3):368-74. doi:10.1161/HYPERTENSIONAHA.117.10237.Stergiou GS, Alpert B, Mieke S, et al. A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. Hypertension. 2018;71(3):368-74. doi:10.1161/HYPERTENSIONAHA.117.10237.Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi:10.1097/HJH.0000000000001940.Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi:10.1097/HJH.0000000000001940.Кобалава Ж. Д., Конради А. О., Недогода С. В. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786.Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.Clark CE, Taylor RS, Shore AC, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012;379(9819):905-14. doi:10.1016/S0140-6736(11)61710-8.Clark CE, Taylor RS, Shore AC, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet. 2012;379(9819):905-14. doi:10.1016/S0140-6736(11)61710-8.Julius S, Palatini P, Kjeldsen SE, et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J Cardiol. 2012;109(5):685-92. doi:10.1016/j.amjcard.2011.10.025.Julius S, Palatini P, Kjeldsen SE, et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J Cardiol. 2012;109(5):685-92. doi:10.1016/j.amjcard.2011.10.025.Zhao J, Han Z, Zhang X, et al. A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension. BMJ Open. 2015;5(6):e007356. doi:10.1136/bmjopen-2014-007356.Zhao J, Han Z, Zhang X, et al. A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension. BMJ Open. 2015;5(6):e007356. doi:10.1136/bmjopen-2014-007356.Кушаковский М. С. Гипертоническая болезнь (эссенциальная гипертензия): причины, механизмы, клиника, лечение. 4-е изд., перераб. и доп. СПб.: Сотис, 1995. 312 с. ISBN: 5-85-503-091-1.Kushakovsky MS. Hypertension (essential hypertension): causes, mechanisms, clinic, treatment. 4th ed., reprint. and additional St. Petersburg: Sotis, 1995. 312 p. (In Russ.) ISBN: 5-85-503-091-1.Nilsson D, Sutton R, Tas W, et al. Orthostatic changes in hemodynamics and cardiovascular biomarkers in dysautonomic patients. PLoS One. 2015;10(6):e0128962. doi:10.1371/journal.pone.0128962.Nilsson D, Sutton R, Tas W, et al. Orthostatic changes in hemodynamics and cardiovascular biomarkers in dysautonomic patients. PLoS One. 2015;10(6):e0128962. doi:10.1371/journal.pone.0128962.Смирнова М. И., Горбунов В. М., Кошеляевская Я. Н. и др. Характеристики больных с воспроизводимой скрытой артериальной гипертонией и подход к ее диагностике. Рациональная Фармакотерапия в Кардиологии. 2019;15(6):789-94. doi:10.20996/1819-6446-2019-15-6-789-794.Smirnova МI, Gorbunov VM, Koshelyaevskaya YN, et al. Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach. Rational Pharmacotherapy in Cardiology. 2019;15(6):789-94. (In Russ.) :10.20996/1819-6446-2019-15-6-789-794.Смирнова М. И., Горбунов В. М., Бойцов С. А. и др. Фенотипы артериального давления в летний и зимний период у больных артериальной гипертонией: внимание на скрытую неэффективность антигипертензивной терапии. Часть 2. Основные маркеры. Рациональная фармакотерапия в кардиологии. 2017;13(6):736-45. doi:10.20996/18196446-2017-13-6-736-745.Smirnova MI, Gorbunov VM, Boytsov SA, et al. Blood pressure phenotypes in treated hypertensive patients in summer and winter: focus on masked uncontrolled hypertension. Part 2. The main markers. Rational Pharmacotherapy in Cardiology. 2017;13(6):736-45. (In Russ.) doi:10.20996/18196446-2017-13-6-736-745.Tabara Y, Igase M, Miki T, et al. J-SHIPP study group. Orthostatic hypertension as a predisposing factor for masked hypertension: the J-SHIPP study. Hypertens Res. 2016;39(9):664-9. doi:10.1038/hr.2016.43.Tabara Y, Igase M, Miki T, et al. J-SHIPP study group. Orthostatic hypertension as a predisposing factor for masked hypertension: the J-SHIPP study. Hypertens Res. 2016;39(9):664-9. doi:10.1038/hr.2016.43.Verwoert GC, Mattace-Raso FU, Hofman A, et al. Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study. J Am Geriatr Soc. 2008;56(10):1816-20. doi:10.1111/j.1532-5415.2008.01946.x.Verwoert GC, Mattace-Raso FU, Hofman A, et al. Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study. J Am Geriatr Soc. 2008;56(10):1816-20. doi:10.1111/j.1532-5415.2008.01946.x.Fedorowski A, Hedblad B, Melander O. Early postural blood pressure response and cause-specific mortality among middleaged adults. Eur J Epidemiol. 2011;26(7):537-46. doi:10.1007/ s10654-011-9578-1.Fedorowski A, Hedblad B, Melander O. Early postural blood pressure response and cause-specific mortality among middleaged adults. Eur J Epidemiol. 2011;26(7):537-46. doi:10.1007/s10654-011-9578-1.Franceschini N, Rose KM, Astor BC, et al. Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension. 2010;56(6):1054-9. doi:10.1161/HYPERTENSIONAHA.110.156380.Franceschini N, Rose KM, Astor BC, et al. Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension. 2010;56(6):1054-9. doi:10.1161/HYPERTENSIONAHA.110.156380.Kario K, Eguchi K, Nakagawa Y, et al. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 1998;31:77-82. doi:10.1161/01.hyp.31.1.77.Kario K, Eguchi K, Nakagawa Y, et al. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 1998;31:77-82. doi:10.1161/01.hyp.31.1.77.Jordan J, Ricci F, Hoffmann F, et al. Orthostatic Hypertension: Critical Appraisal of an Overlooked Condition. Hypertension. 2020;75(5):1151-8. doi:10.1161/HYPERTENSIONAHA.120.14340.Jordan J, Ricci F, Hoffmann F, et al. Orthostatic Hypertension: Critical Appraisal of an Overlooked Condition. Hypertension. 2020;75(5):1151-8. doi:10.1161/HYPERTENSIONAHA.120.14340.Wijkman M, Länne T, Östgren CJ, et al. Diastolic orthostatic hypertension and cardiovascular prognosis in type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2016;15:83. doi:10.1186/s12933-016-0399-0.Wijkman M, Länne T, Östgren CJ, et al. Diastolic orthostatic hypertension and cardiovascular prognosis in type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2016;15:83. doi:10.1186/s12933-016-0399-0.Brignole M, Moya A, De Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-948. doi:10.1093/eurheartj/ehy037.Brignole M, Moya A, De Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-948. doi:10.1093/eurheartj/ehy037.Ткачева О. Н., Котовская Ю. В., Рунихина Н. К. и др. Клинические рекомендации "Старческая астения". Российский журнал гериатрической медицины. 2020;(1):11-46. doi:10.37586/2686-8636-1-2020-11-46.Tkacheva ON, Kotovskaya YuV, Runikhina NK, et al. Clinical recommendations "Senile asthenia". Russian Journal of Geriatric Medicine. 2020;(1):11-46. (In Russ.)Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996;46(5):1470. doi:10.1212/wnl.46.5.1470.Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996;46(5):1470. doi:10.1212/wnl.46.5.1470.Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am. J. Med. 2007;120(10):841-7. doi:10.1016/j.amjmed.2007.02.023.Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am. J. Med. 2007;120(10):841-7. doi:10.1016/j.amjmed.2007.02.023.Magkas N, Tsioufis C, Thomopoulos C, et al. Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens (Greenwich). 2019;21(3):426-33. doi:10.1111/jch.13491.Magkas N, Tsioufis C, Thomopoulos C, et al. Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens (Greenwich). 2019;21(3):426-33. doi:10.1111/jch.13491.Kario K. Orthostatic hypertension — a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol. 2013;9(12):726-38. doi:10.1038/nrneph.2013.224.Kario K. Orthostatic hypertension — a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol. 2013;9(12):726-38. doi:10.1038/nrneph.2013.224.Nibouche-Hattab WN, Lanasri N, Zeraoulia F, et al. Orthostatic hypertension in normotensive type 2 diabetics: What characteristics? Ann Cardiol Angeiol (Paris). 2017;66(3):159-64. doi:10.1016/j.ancard.2017.04.003.Nibouche-Hattab WN, Lanasri N, Zeraoulia F, et al. Orthostatic hypertension in normotensive type 2 diabetics: What characteristics? Ann Cardiol Angeiol (Paris). 2017;66(3):159-64. doi:10.1016/j.ancard.2017.04.003.Filipovsky J, Seidlerova J, Kratochvil Z, et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. J Blood Pressure. 2016;25(4):228-34. doi:10.3109/08037051.2015.1134086.Filipovsky J, Seidlerova J, Kratochvil Z, et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. J Blood Pressure. 2016;25(4):228-34. doi:10.3109/08037051.2015.1134086.Gorbunov VM. Daily monitoring of arterial pressure: modern aspects. M.: Logosphere, 2015. p. 240. (In Russ.) Горбунов В. М. Суточное мониторирование артериального давления: современные аспекты. М.: Логосфера, 2015. С. 240.Gorbunov VM. Daily monitoring of arterial pressure: modern aspects. M.: Logosphere, 2015. p. 240. (In Russ.) Горбунов В. М. Суточное мониторирование артериального давления: современные аспекты. М.: Логосфера, 2015. С. 240.Рогоза А. Н., Никольский В. П., Ощепкова Е. В. и др. Суточное мониторирование артериального давления при гипертонии. Методические вопросы. 1996. С. 37.Rogoza AN, Nikolsky VP, Oshchepkova EV, et al. Daily monitoring of blood pressure in hypertension. Methodological issues. 1996. p. 37. (In Russ.)Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359-66. doi:10.1097/HJH.0000000000000221.Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359-66. doi:10.1097/HJH.0000000000000221.Рогоза А. Н., Ощепкова Е. В., Цагареишвили Е. В. и др. Современные неинвазивные методы измерения артериального давления для диагностики артериальной гипертонии и оценки эффективности антигипертензивной терапии. Пособие для врачей. 2007. с. 72.Rogoza AN, Oschepkova EV, Tsagareishvili EV, et al. Modern non-invasive methods of blood pressure measurement for the diagnosis of arterial hypertension and evaluation of the effectiveness of antihypertensive therapy. A manual for doctors. 2007. p. 72. (In Russ.)Omboni S, Gazzola T, Carabelli G, et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013;31(3):455-67; discussion 467-8. doi:10.1097/HJH.0b013e32835ca8dd.Omboni S, Gazzola T, Carabelli G, et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013;31(3):455-67; discussion 467-8. doi:10.1097/HJH.0b013e32835ca8dd.Бойцов С. А., Комков Д. С., Вальденберг А. В. и др. Методика проведения дистанционного диспансерного наблюдения. Приложение к Методическим рекомендациям "Диспансерное наблюдение больных хроническими неинфекционными заболеваниями и пациентов с высоким риском их развития" под редакцией Бойцова С.А., Чучалина А.Г. (2014г.). М.: 2016. с. 31. https://org.gnicpm.ru/wp-content/uploads/2018/11/Metodika_DDN_vers-2.pdf.Boytsov SA, Komkov DS, Waldenberg AV, et al. The methodology of remote dispensary observation. Appendix to the Methodological recommendations "Dispensary observation of patients with chronic non-communicable diseases and patients at high risk of their development" edited by S.A. Boytsov, A.G. Chuchalin (2014). M.: 2016. p. 31. (In Russ.) https://org.gnicpm.ru/wp-content/uploads/2018/11/Metodika_DDN_vers-2.pdf.Рогоза А. Н., Гориева Ш. Б., Мордвинова Е. В. Возможности тонометров высокого класса точности в обеспечении дистанционного самоконтроля артериального давления. РМЖ. 2014;22(23):1707-13.Rogoza AN, Gorieva ShB, Mordvinova EV. Possibilities of highclass precision tonometers in providing remote self-monitoring of arterial pressure. Breast cancer. 2014;22(23):1707-13. (In Russ.)Parati G, Ochoa JE, Bilo G. Moving Beyond Office Blood Pressure to Achieve a Personalized and More Precise Hypertension Management: Which Way to Go? Hypertension. 2017;3(70):20-31. doi:10.1161/HYPERTENSIONAHA.117.08250.Parati G, Ochoa JE, Bilo G. Moving Beyond Office Blood Pressure to Achieve a Personalized and More Precise Hypertension Management: Which Way to Go? Hypertension. 2017;3(70):20-31. doi:10.1161/HYPERTENSIONAHA.117.08250.Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35(3):844-51. doi:10.1161/01.hyp.35.3.844.Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35(3):844-51. doi:10.1161/01.hyp.35.3.844.Salles GF, Reboldi G, Fagard RH, et al.; ABC-H Investigators. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the Ambulatory Blood pressure Collaboration in patients with Hypertension (ABC-H) metaanalysis. Hypertension. 2016;67(4):693-700. doi:10.1161/HYPERTENSIONAHA.115.06981.Salles GF, Reboldi G, Fagard RH, et al.; ABC-H Investigators. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the Ambulatory Blood pressure Collaboration in patients with Hypertension (ABC-H) metaanalysis. Hypertension. 2016;67(4):693-700. doi:10.1161/HYPERTENSIONAHA.115.06981.Машин В. В., Грищук Д. В., Альберт М. А. Факторы и маркеры риска развития различных подтипов ишемического инсульта. Ульяновский медико-биологический журнал. 2013;(1):8-14.Mashin VV, Grischuk DV, Albert MA. Risk factors and markers for the development of various subtypes of ischemic stroke. Ulyanovsk Medical and Biological Journal. 2013;(1):8-14. (In Russ.)Björklund K, Lind L, Zethelius B, et al. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens. 2004;22(9):1691-7. doi:10.1097/00004872-20040900000012.Björklund K, Lind L, Zethelius B, et al. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens. 2004;22(9):1691-7. doi:10.1097/00004872-20040900000012.Conen D, Ridker PM, Buring JE, et al. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335(7617):432. doi:10.1136/bmj.39269.672188.AE.Conen D, Ridker PM, Buring JE, et al. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335(7617):432. doi:10.1136/bmj.39269.672188.AE.Amici A, Cicconetti P, Sagrafoli C, et al. Exaggerated morning blood pressure surge and cardiovascular events. A 5-year longitudinal study in normotensive and well-controlled hypertensive elderly. Arch Gerontol Geriatr. 2009;49(2):105-9. doi:10.1016/j.archger.2008.10.003.Amici A, Cicconetti P, Sagrafoli C, et al. Exaggerated morning blood pressure surge and cardiovascular events. A 5-year longitudinal study in normotensive and well-controlled hypertensive elderly. Arch Gerontol Geriatr. 2009;49(2):105-9. doi:10.1016/j.archger.2008.10.003.Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401-6. doi:10.1161/01.cir.0000056521.67546.aa.Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401-6. doi:10.1161/01.cir.0000056521.67546.aa.Li Y, Thijs L, Hansen TW, et al. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55(4):1040-8. doi:10.1161/HYPERTENSIONAHA.109.137273.Li Y, Thijs L, Hansen TW, et al. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55(4):1040-8. doi:10.1161/HYPERTENSIONAHA.109.137273.Кобалава Ж. Д. Котовская Ю. В. Мониторирование артериального давления: методические аспекты и клиническое значение. М, 1999. С. 234.Kobalava ZhD, Kotovskaya YuV. Blood pressure monitoring: methodological aspects and clinical significance. M, 1999. p. 234. (In Russ.)Tissot AC, Maurer P, Nussberger J, et al. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind randomized, placebo-controlled phase IIa study. Lancet. 2008;371(9615):821-7. doi:10.1016/S01406736(08)60381-5.Tissot AC, Maurer P, Nussberger J, et al. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind randomized, placebo-controlled phase IIa study. Lancet. 2008;371(9615):821-7. doi:10.1016/S01406736(08)60381-5.Гориева Ш. Б., Рогоза А. Н. Точность измерения артериального давления при постоянной форме фибрилляции предсердий. РМЖ. 2013:21(12):629-33.Gorieva ShB, Rogoza AN. Accuracy of blood pressure measurement with a constant form of atrial fibrillation. RMJ. 2013:21(12):629-33. (In Russ.)O’Brien E, Parati G, Stergiou G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731-68. doi:10.1097/HJH.0b013e328363e964.O’Brien E, Parati G, Stergiou G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731-68. doi:10.1097/HJH.0b013e328363e964.Parati G, Stergiou GS, Asmar R, et al.; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26(8):150526. doi:10.1097/HJH.0b013e328308da66.Parati G, Stergiou GS, Asmar R, et al.; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26(8):150526. doi:10.1097/HJH.0b013e328308da66.Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-15. doi:10.1016/j.jacc.2005.03.070.Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-15. doi:10.1016/j.jacc.2005.03.070.Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res. 2007;30(6):479-88. doi:10.1291/hypres.30.479.Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res. 2007;30(6):479-88. doi:10.1291/hypres.30.479.Piper MA, Evans CV, Burda BU, et al. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(3):192-204. doi:10.7326/M14-1539.Piper MA, Evans CV, Burda BU, et al. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(3):192-204. doi:10.7326/M14-1539.Bobrie G, Clerson P, Ménard J, et al. Masked hypertension: a systematic review. J Hypertens. 2008;26(9):1715-25. doi:10. 1097/HJH.0b013e3282fbcedf.Bobrie G, Clerson P, Ménard J, et al. Masked hypertension: a systematic review. J Hypertens. 2008;26(9):1715-25. doi:10.1097/HJH.0b013e3282fbcedf.Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):21938. doi:10.1097/HJH.0b013e3282ef6185.Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):21938. doi:10.1097/HJH.0b013e3282ef6185.Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357. doi:10.1097/01.hjh.0000431740.32696.cc.Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357. doi:10.1097/01.hjh.0000431740.32696.cc.Ng CM, Yiu SF, Choi KL, et al. Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics. Hong Kong Med J. 2008;14(6):437-43.Ng CM, Yiu SF, Choi KL, et al. Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics. Hong Kong Med J. 2008;14(6):437-43.Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5):846-53. doi:10.1161/01.HYP.0000215363.69793.bb.Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5):846-53. doi:10.1161/01.HYP.0000215363.69793.bb.Stergiou GS, Asayama K, Thijs L, et al.; International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63(4):675-82. doi:10.1161/HYPERTENSIONAHA.113.02741.Stergiou GS, Asayama K, Thijs L, et al.; International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63(4):675-82. doi:10.1161/HYPERTENSIONAHA.113.02741.Redmond N, Booth JN 3rd, Tanner RM, et al. Prevalence of Masked Hypertension and Its Association With Subclinical Cardiovascular Disease in African Americans: Results From the Jackson Heart Study. J Am Heart Assoc. 2016;5(3):e002284. doi:10.1161/JAHA.115.002284.Redmond N, Booth JN 3rd, Tanner RM, et al. Prevalence of Masked Hypertension and Its Association With Subclinical Cardiovascular Disease in African Americans: Results From the Jackson Heart Study. J Am Heart Assoc. 2016;5(3):e002284. doi:10.1161/JAHA.115.002284.Peacock J, Diaz KM, Viera AJ, et al. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28(9):521-8. doi:10.1038/jhh.2014.9.Peacock J, Diaz KM, Viera AJ, et al. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28(9):521-8. doi:10.1038/jhh.2014.9.Kario K. Early morning risk management in hypertension. Current Medicine Group Ltd., 2005, 68 p.Kario K. Early morning risk management in hypertension. Current Medicine Group Ltd., 2005, 68 p.Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014;35(46):3304-12. doi:10.1093/eurheartj/ehu016.Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014;35(46):3304-12. doi:10.1093/eurheartj/ehu016.Смирнова М. И., Горбунов В. М., Бойцов С. А. и др. Фенотипы артериального давления в летний и зимний период у больных артериальной гипертонией: внимание на скрытую неэффективность антигипертензивной терапии. Часть 1: частота фенотипов. Рациональная фармакотерапия в кардиологии. 2017;13(5):578-89. doi:10.20996/18196446-2017-13-5-578-589.Smirnova MI, Gorbunov VM, Boytsov SA, et al. Blood pressure phenotypes in treated hypertensive patients in summer and winter: focus on masked uncontrolled hypertension. Part 1: blood pressure phenotypes prevalence. Rational Pharmacotherapy in Cardiology. 2017;13(5):578-89. (In Russ.) doi:10.20996/18196446-2017-13-5-578-589.Ishikava J, Kario K, Eguchi K, et al. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Hypertens Res. 2006;29(9):679-86. doi:10.1291/hypres.29.679.Ishikava J, Kario K, Eguchi K, et al. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Hypertens Res. 2006;29(9):679-86. doi:10.1291/hypres.29.679.Drawz PE, Alper AB, Anderson AH, et al.; Chronic Renal Insufficiency Cohort Study Investigators. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. Clin J Am Soc Nephrol. 2016;11(4):642-52. doi:10.2215/CJN.08530815.Drawz PE, Alper AB, Anderson AH, et al.; Chronic Renal Insufficiency Cohort Study Investigators. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. Clin J Am Soc Nephrol. 2016;11(4):642-52. doi:10.2215/CJN.08530815.Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52-8. doi:10.1038/ajh.2010.203.Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52-8. doi:10.1038/ajh.2010.203.Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509-20. doi:10.1056/NEJMoa1712231.Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509-20. doi:10.1056/NEJMoa1712231.Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure selfmeasurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342-9. doi:10.1001/jama.291.11.1342.Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure selfmeasurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342-9. doi:10.1001/jama.291.11.1342.Franklin SS, Thijs L, Li Y, et al. Response to masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations and response to Is masked hypertension related to diabetes mellitus? Hypertension. 2013;62(4):23-5. doi:10.1161/hypertensionaha.113.01700.Franklin SS, Thijs L, Li Y, et al. Response to masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations and response to Is masked hypertension related to diabetes mellitus? Hypertension. 2013;62(4):23-5. doi:10.1161/hypertensionaha.113.01700.Stergiou GS, Palatini P, Modesti PA, et al. Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J Hypertens. 2020;38(7):123543. doi:10.1097/HJH.0000000000002341.Stergiou GS, Palatini P, Modesti PA, et al. Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J Hypertens. 2020;38(7):123543. doi:10.1097/HJH.0000000000002341.Duan Y, Xie Z, Dong F, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and metaanalysis of randomised controlled studies. J Hum Hypertens. 2017;31(7):427-37. doi:10.1038/jhh.2016.99.Duan Y, Xie Z, Dong F, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and metaanalysis of randomised controlled studies. J Hum Hypertens. 2017;31(7):427-37. doi:10.1038/jhh.2016.99.Диспансерное наблюдение больных хроническими неинфекционными заболеваниями и пациентов с высоким риском их развития. Методические рекомендации. Под ред. Бойцова С.А. и Чучалина А.Г. М: 2014. С. 112.Dispensary obser vation of patients with chronic noncommunicable diseases and patients at high risk of their development. Methodological recommendations. Ed. Boitsov S.A., Chuchalin A.G. M: 2014. p. 112. (In Russ.)Михайлов А. А. Хроническая артериальная гипотензия: возможности медикаментозной коррекции. Русский медицинский журнал: независимое издание для практикующих врачей. 2004;12(7):468-70.Mikhailov AA. Chronic arterial hypotension: possibilities of drug correction. Russian Medical Journal: an independent publication for practicing physicians. 2004;12(7):468-70. (In Russ.)Kudina EV, Radchik II, Larina VN. Arterial hypotension: diagnosis, non-drug and drug treatment methods. Medical business. 2015;(2):4-9. (In Russ.) Кудина Е. В., Рачек И. И., Ларина В. Н. Артериальная гипотензия: диагностика, немедикаментозные и медикаментозные методы лечения. Лечебное дело. 2015;(2):4-9.Kudina EV, Radchik II, Larina VN. Arterial hypotension: diagnosis, non-drug and drug treatment methods. Medical business. 2015;(2):4-9. (In Russ.)Ricci F, De Caterina R, Fedorowski A. Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. J Am Coll Cardiol. 2015;18;66(7):848-60. doi:10.1016/j.jacc.2015.06.1084.Ricci F, De Caterina R, Fedorowski A. Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. J Am Coll Cardiol. 2015;18;66(7):848-60. doi:10.1016/j.jacc.2015.06.1084.Vertkin AL, Volobuev PM, Moskvichev VG, et al. Arterial hypotension: pathogenesis, diagnosis, treatment. Pharmateca. 2012;17:108-11. (In Russ.) Верткин А. Л., Волобуев П. М., Москвичев В. Г. и др. Артериальная гипотензия: патогенез, диагностика, лечение. Фарматека. 2012;17:108-11.Vertkin AL, Volobuev PM, Moskvichev VG, et al. Arterial hypotension: pathogenesis, diagnosis, treatment. Pharmateca. 2012;17:108-11. (In Russ.)Литовченко Т. А., Зинченко Е. К. Артериальная гипотония — начальный этап формирования хронической недостаточности мозгового кровообращения (особенности лечения). Международный неврологический журнал. 2011;6(44):70-4.Litovchenko TA, Zinchenko EK. Arterial hypotension — the initial stage of the formation of chronic cerebral circulatory insufficiency (treatment features). International Neurological Journal. 2011;6(44):70-4. (In Russ.)

The authors declare that there are no conflicts of interest present.